ArticlePloS one2022

Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.

Chijioke N Umunnakwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.